CINECA IRIS Institutional Research Information System

Sfoglia per Autore  

Opzioni
Mostrati risultati da 81 a 100 di 178
Titolo Data di pubblicazione Autore(i) File
Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy 2010 Sierra JR; Cepero V; Giordano S.
MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors. 2010 V. Cepero;J. R. Sierra;S. Corso;E. Ghiso;L. Casorzo;T. Perera;P. M. Comoglio;S. Giordano
Il cancro 2009 G. Del Sal; S. Giordano
La comunicazione intercellulare 2009 S. Giordano
Only a subset of Met-activated pathways are required to sustain oncogene addiction 2009 Bertotti A; Burbridge MF; Gastaldi S; Galimi F; Torti D; Medico E; Giordano S; Corso S; Rolland-Valognes G; Lockhart BP; Hickman JA; Comoglio PM; Trusolino L.
Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis 2009 Foveau B; Ancot F; Leroy C; Petrelli A; Reiss K; Vingtdeux V; Giordano S; Fafeur V; Tulasne D.
MiRNAs as new master players 2009 Migliore C.; Giordano S.
Rilotumumab, a mAb against human hepatocyte growth factor for the treatment of cancer. 2009 Giordano S
MicroRNAs impair MET-mediated invasive growth 2008 Cristina Migliore; Annalisa Petrelli; Elena Ghiso; Simona Corso; Lorena Capparuccia; Adriana Eramo; Paolo M.Comoglio; Silvia Giordano
Molecular cancer therapy: can our expectation be met? 2008 Migliore C; Giordano S.
Semaphorin 4D regulates gonadotropin hormone-releasing Hormone-1 neuronal migration through Plexin B1-Met Complex 2008 P. GIACOBINI; A. MESSINA; F. MORELLO; N. FERRARIS; S. CORSO; J. PENACHIONI; S. GIORDANO; L. TAMAGNONE; A. FASOLO
From single- to multi- target drugs in cancer therapy: when aspecificity becomes an advantage 2008 Petrelli A.; Giordano S
Drug development of met inhibitors: targeting oncogene addiction and expedience 2008 P.M. Comoglio; S. Giordano; L. Trusolino
Silencing the MET oncogene leads to regression of experimental tumors and metastases 2008 CORSO S; MIGLIORE C; GHISO E; DE ROSA G; COMOGLIO P; GIORDANO S
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages 2008 Sierra JR; Corso S; Caione L; Cepero V; Conrotto P; Piacibello W; Kumanogoh A; Kikutani H; Comoglio P; Tamagnone L; Giordano S.
Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products 2007 COMOGLIO Paolo Maria; VIGNA Elisa; GIORDANO Silvia
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling 2007 SHTIEGMAN K; KOCHUPURAKKAL BS; ZWANG Y; PINES G; STARR A; VEXLER A; CITRI A; KATZ M; LAVI S; BEN-BASAT Y; BENJAMIN S; CORSO S; GAN J; YOSEF RB; GIORDANO S; YARDEN Y
MET overexpression turns human primary osteoblasts into osteosarcomas 2006 PATANE S; AVNET S; COLTELLA N; COSTA B; SPONZA S; OLIVERO M; VIGNA E; NALDINI L; BALDINI N; FERRACINI R; CORSO S; GIORDANO S; COMOGLIO PM; DI RENZO MF
Signaling from internalized receptors. 2006 Polo S; Lanzetti L; Giordano S.
Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS) 2006 D FERRARO; S CORSO; E FASANO; E PANIERI; R SANTANGELO; S BORRELLO; S. GIORDANO; G PANI AND T GALEOTTI
Mostrati risultati da 81 a 100 di 178
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile